ICD-10-CM Billable Code

C7A.094

Malignant carcinoid tumor of the foregut, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

A malignant carcinoid tumor of the foregut, classified under ICD-10 code C7A.094, is a rare type of cancer that arises from neuroendocrine cells in the upper part of the digestive system. The foregut includes the esophagus, stomach, and the initial part of the small intestine. This tumor is considered malignant because it has the potential to grow aggressively and spread to other parts of the body. Due to its location and nature, it may present with various symptoms that can be mistaken for other conditions, making accurate diagnosis vital for effective management.

Causes & Symptoms

Clinical Causes: Genetic mutations leading to abnormal cell growth Inherited syndromes that increase risk for neuroendocrine tumors Environmental factors, although specific causes are largely unknown Chronic inflammation or damage to the foregut structures

Key Symptoms: Abdominal pain or discomfort Unexplained weight loss Digestive disturbances such as nausea, vomiting, or diarrhea Feeling of fullness or early satiety Carcinoid Syndrome symptoms, including flushing, wheezing, or rapid heartbeat (occasionally occurs if the tumor secretes hormones) Blood in stool or black, tarry stools in some cases

Diagnostic & Treatment

Diagnosis Path: Medical history review and physical examination Imaging tests such as computed tomography (CT) scan, magnetic resonance imaging (MRI), or somatostatin receptor scintigraphy to locate tumors and evaluate spread Biopsy of the suspected tumor tissue for histopathological examination Laboratory tests including blood and urine analysis to detect hormone secretion or tumor markers Endoscopy procedures, such as esophagogastroduodenoscopy (EGD), to visualize the tumor directly

Treatment Protocols: Surgical resection to remove tumor tissue and affected areas Targeted therapies such as somatostatin analogs to control hormone-related symptoms and tumor growth Chemotherapy or palliative treatments in advanced cases Radiation therapy, although less common, may be used for localized control Monitoring and management of carcinoid syndrome symptoms if present Regular follow-up with imaging and blood tests to detect recurrence or metastasis

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C7A.094 a billable ICD-10 code?
Yes, C7A.094 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C7A.094?
Clinical documentation must specify the nature of Malignant carcinoid tumor of the foregut, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference